Antipsychotics, ECGs, QTcs and Catastrophes
In 2001 the FDA in the USA put a “black box” warning on droperidol after a series of case reports linking it with torsades de pointes. Since then there have been lot of cases of antipsychotic-related cardiac badness and it is fair to say this is something psychiatrists worry about. It would be nice to live in a world where we could do a 12-lead ECG, say “hey – the QTc is normal, so it is OK to use all these meds”…. but alas, medicine is never that simple
I thought I would take a look at the evidence, try and work out if there is a way to predict who will get toxicity, and when it is safe. What can we do in a practical sense to try and minimise the risk of cardiac toxicity. So lets get done to basics.
Firstly, which medications are associated with prolonged QTc, and how severe is this effect
Table 5: Relative Risk of Psychotropics that may have an Effect on QTc
No Effect |
Low Effect |
Moderate Effect |
High Effect |
Unknown Effect |
Aripiprazole Paliperidone SSRIs(except citalopram) Reboxetine Mirtazapine MAOIs Carbamazepine Gabapentin Lamotrigine Valproate Benzodiazepines |
Amisulpride Clozapine Flupenthixol Fluphenazine Olanzapine Risperidone Citalopram Moclobemide Venlafaxine Lithium Bupropion Prochlorperazine |
Chlorpromazine Quetiapine Ziprasidone TCAs |
Haloperidol Methadone Pimozide |
Pipothiazine |
So, pretty much a lot of the drugs that psychiatrists or ED docs might be prescribing in acutely agitated patients are on the list. If you are like me you cannot remember all these names with lots of Xs and Zs in them – so safe to assume anything psychiatric that is not in the left most column is potentially a problem.
It seems to be the dose, NOT the drug i.e. toxicity is dose-related – so in summary : DON’T POISON YOUR PATIENT!
There seem to be many different recognised “normals”. I am just going to tell you the commonly quoted ones: 440 msec for boys and 460 msec for ladies.
Now here is the clincher – there does not seem to be a clear relationship between the QTc and the incidence of torsades or sudden cardiac death. However, the rate of TdP seems to go up significantly once your QTc is > 500 ms. The numbers are hard to pick out as it is often a retrospective diagnosis. So what should we do with a QTc once we have measured it?
- Correct the QT int. for heart rate using the “nomogram” Great review from Q J Med 2007 includes the nomogram.
- If it is normal, great – check for other risk factors.
- If it is 450 – 500 ms, I think you should consider using other agents, and you need to check other reversible risk factors are corrected if you are using antipsychotics
- Over 500 ms – where angels fear… I think all bets are off. Don’t use any potential QT stretching agents if this is the starting point!
So here is the super short ‘n sweet summary for avoiding cardiac badness when using antipsychotic agents:
1. Assess background risk: history, FHx, cardiac disease etc
2. Do the baseline ECG looking for long QTc AND other potential problems.
3. Check the electrolytes, especially K and Mg
4. Get a clear picture of other drugs that are in the system e.g..depot meds
5.
Avoid multiple agents which also have QTc problems. For example, adding haloperidol to droperidol doesn’t make much sense to me – pick one and give a good dose.
6. If you have given a pile of drugs – then repeat the ECG, check for signs of toxicity – long QTc etc. If there are changes – then you need to do full monitoring.
Ok, let me know your thoughts. Is this something you worry about?
Casey
G’day Casey,
Several points :
The droperidol QT prolongation is second only to “who killed JFK” as a conspiracy theory. In essence the black box warning arose from 106 cases of droperidol related cardiac toxicity over 35 years. Sounds ok till you realise that 71/106 were reported in a single day in 2001 (YES a single day)
The DORM study provides good evidence of droperidol being better and safer than benzodiazepines albeit in a small sample.
DORM II presented at SAEM in MAY showed no evidence of droperidol related QT prolongation in a sample size of > 500, study will terminate when 1000 cases enrolled.
I would not use the QTc to assess the QT interval for TdP risk in drug or toxin related prolongation. Use the QT nomogram, it is more sensitive and has a better evidence base. QTc uses Bazzet’s formula which undercorrects QTc at heart rates > 70-80 and overcorrects at heart rates < 50 thus give falsely low QT values at low heart rates – where TdP is much more likely to occur – and an overestimation of QT length at high heart rates. As a result drugs like quetiapine and bupropion are reported to cause QT prolongation in overdose, but they don't cause TdP ??? It's because the sinus tachycardia induced in overdose by these drugs causes the ECG machine to record an artificially high QTc as a result of using Bazzet's formula.
The issue of what drugs do and don't cause prolonged QT is very dogmatic. TCAs are often quoted but in fact the main toxicity related to TCAs is QRS prolongation – this of course will inevitably lead to a prolongation in the QT interval but is spurious.
Haloperidol does cause QT prolongation as does Amisulpride (the latter described facetiously by a colleague of mine as a "designer drug" ie designed to cause TdP)
Droperidol IM 10 mg is a safe and efficacious treatment for the agitated/drug affected patient, can be repeated again in 10 minutes if desired level of sedation not achieved – do not worry about QT.
Happy to post references to support my stance, just would have to dig them out.
Michael
Thanks Michael
Great points – this is a really confusing area for a lot of us.
Have added the excellent review on QTc nomogram from Qld Uni
See: http://www.health.qld.gov.au/poisonsinformationcentre/docs/qt_prolongation.pdf
PLease send me your references – I think that I might be getting into some discussion around this in my world soon!
Casey
Hi Casey,
This article details the farcical evidence behind droperidol
http://www.ncbi.nlm.nih.gov/pubmed/12045077
The DORM study
http://www.ncbi.nlm.nih.gov/pubmed/20868907
DORM II ongoing, presented in poster form earlier this year – 424 patients given droperidol, 273 ECGs avaiable for review, 4/273 above the at risk line on QT nomogram, all had confounding variables that could explain QT prolongation, recruitment will stop when 1000 cases enrolled
You already have the nomogram v QTc article as above
Amisulpride
http://www.ncbi.nlm.nih.gov/pubmed/16584372
I couldn’t work out how to post files to the site otherwise could have uploaded. Can email to you if you wish.
Michael